{"id":"W2904237382","doi":"10.3747/co.25.4213","title":"Developing a Model of a Patient-Group Pathway to Accessing Cancer Clinical Trials in Canada","year":2018,"lang":"en","type":"article","venue":"Current Oncology","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute for Research in Immunology and Cancer; Robarts Clinical Trials; Jewish General Hospital","funders":"Eli Lilly Canada; Partenariat Canadien Contre Le Cancer; F. Hoffmann-La Roche; Bristol-Myers Squibb; Eli Lilly and Company; Merck Canada; Innovative Medicines Canada","keywords":"Stakeholder; Clinical trial; Medicine; Stakeholder engagement; General partnership; Inclusion (mineral); Working group; Alternative medicine; Family medicine; Public relations; Medical education; Political science; Psychology; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":true,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02569917,0.0008529937,0.000497788,0.002365301,0.01127612,0.01447431,0.005182075,0.005236124,0.01253238],"category_scores_gemma":[0.04292175,0.0008321928,0.001526615,0.003426859,0.007621253,0.004751156,0.009217044,0.004259035,0.002169448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.1020997,"about_ca_system_score_gemma":0.3470909,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8568351,"about_ca_topic_score_gemma":0.8861321,"domain_scores_codex":[0.9727539,0.01457738,0.001020198,0.002065339,0.005486873,0.004096299],"domain_scores_gemma":[0.9631305,0.009787324,0.001349955,0.001660198,0.01481595,0.009255942],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"qualitative","study_design_scores_codex":[0.0004973207,0.0004093883,0.01698326,0.001208491,0.0001275093,0.002928032,0.04100225,0.07085824,0.001361572,0.7075989,0.06387874,0.0931462],"study_design_scores_gemma":[0.0005786333,0.0003469087,0.005967122,0.001879276,0.0001903149,0.0006928161,0.02960437,0.1088349,0.00147702,0.2041003,0.6459627,0.0003656853],"study_design_candidate":"qualitative","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.0626058,0.00203113,0.3028974,0.171753,0.001497393,0.008877996,0.003391799,0.001840605,0.4451048],"genre_scores_gemma":[0.5401972,0.002229527,0.403626,0.007789736,0.0001139306,0.003083508,0.002425794,0.0002224543,0.04031178],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.1431649,"threshold_uncertainty_score":0.7407886,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.83372816234055,"score_gpt":0.6846758041663639,"score_spread":0.1490523581741862,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}